SHRM.CN

Champignon Brands

53 views0 min read

Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond

Braxia Scientific
ReutersCryptoverse: Holding your breath for a bitcoin bounceBitcoin's slide since May, swamped by economic angst, has knocked it below its 200-week moving average, at around $22,600, as well as its 200-day moving average around $35,500. Valkyrie Investments, for one, says its research is pointing to an upside move - but that it isn't clea... Read More...
207 views5 min read

Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

Braxia Scientific
VANCOUVER, British Columbia, Aug. 27, 2020 -- Champignon Brands Inc. (CSE: SHRM) (the “Company” or “Champignon”) is expanding its rapid-onset treatment service for major depressive disorder (“MDD”). Champignon will offer esketamine for the treatment of adults with MDD at its flagship clinic starting in September 2020. Ketamine was declare... Read More...
1003 views4 min read

Champignon Announces Regulatory Review

Braxia Scientific
VANCOUVER, British Columbia, June 22, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF) announces that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”).  The review relates to the Company’s disclosure obligations since it became ... Read More...
388 views6 min read

Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out

Braxia Scientific
VANCOUVER, British Columbia, June 12, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, since commencing trading on March 2, 2020 has expanded its initiatives and rapidly executed on such initiat... Read More...
1367 views5 min read

Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

Braxia Scientific
VANCOUVER, British Columbia, June 08, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is pleased to announce it has selected Toronto-based Dalriada Drug Discovery Inc. (“Dalriada”) to advance its new chemi... Read More...
108 views5 min read

Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors

Braxia Scientific
VANCOUVER, British Columbia, May 25, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to augment its board of directors through the appointment of accomplished business executives and ... Read More...
34 views4 min read

Champignon Appoints Pat McCutcheon to Board of Directors

Braxia Scientific
VANCOUVER, British Columbia, May 06, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleas... Read More...
29 views7 min read

Le traitement Ă  base de kĂ©tamine de Champignon sera distribuĂ© par une importante chaĂ®ne de pharmacie canadienne et la compagnie annonce la clĂ´ture de la transaction d’AltMed

Braxia Scientific
VANCOUVER, Colombie-Britannique, April 30, 2020 -- Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTCQB : SHRMF), une société des sciences de l’optimisation humaine concentrée sur l’application de nouveaux protocoles de traitement naturels mettant l’accent sur la médecine psychédélique afin de traiter ... Read More...
24 views4 min read

Champignon Selected as Headline Partner for PSYCH: The Psychedelics Symposium at Prohibition Partners LIVE

Braxia Scientific
VANCOUVER, British Columbia, April 28, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is ple... Read More...
32 views3 min read

Champignon Commences U.S. Trading on the OTCQB Venture Market Under Ticker Symbol “SHRMF”

Braxia Scientific
VANCOUVER, British Columbia, April 23, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to anno... Read More...
23 views4 min read

Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami

Braxia Scientific
VANCOUVER, British Columbia, April 22, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to advan... Read More...
14 views4 min read

Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee

Braxia Scientific
VANCOUVER, British Columbia, April 16, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, has further bolste... Read More...
M & A15 views8 min read

Champignon to Acquire AltMed Capital Corp.

Braxia Scientific
VANCOUVER, British Columbia, April 09, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to accel... Read More...
16 views4 min read

Champignon Featured in Broadcast on Mental Health Options, Medical Mushrooms

Braxia Scientific
NEW YORK, April 03, 2020 -- via NetworkNewsAudio – Champignon Brands Inc. (SHRMF) (SHRM.CN) announces the availability of a broadcast titled, “Medical Mushroom Companies Expand as People Seek New Mental Health Treatments”.To hear the AudioPressRelease from NetworkNewsAudio, visit: http://nnw.fm/jK5M3To read the full editorial, visit: http... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!